UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Garcia-Pavia, Pablo; Rapezzi, Claudio; Adler, Yehuda; Arad, Michael; Basso, Cristina; Brucato, Antonio; Burazor, Ivana; ... Linhart, Ales; + view all (2021) Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Journal of Heart Failure , 23 (4) pp. 512-526. 10.1002/ejhf.2140. Green open access

[thumbnail of Article]
Preview
Text (Article)
Gillmore_Position Statement Diagnosis&treatment Cardiac Amyloidosis. 28.04.20.pdf

Download (373kB) | Preview
[thumbnail of Tables]
Preview
Text (Tables)
Gillmore_Position Statement Tables. 28.4.20.pdf

Download (262kB) | Preview
[thumbnail of Supplemental material]
Preview
Text (Supplemental material)
Gillmore_Position Statement Supplemental Material.27.4.20.pdf

Download (293kB) | Preview

Abstract

Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice.

Type: Article
Title: Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/ejhf.2140
Publisher version: https://doi.org/10.1002/ejhf.2140
Language: English
Keywords: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10160069
Downloads since deposit
62Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item